North Carolina, USA-based biotech BioCryst Pharmaceuticals on Friday announced it has signed a definitive agreement to sell ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...

US biotech Arbutus Biopharma (Nasdaq: ABUS) has reacquired the rights to its lead hepatitis B candidate, imdusiran (AB-729), ...

Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

German drugmaker Bayer (BAYN: DE) has renewed its partnership with China’s Tsinghua University for another three years, ...

German biosimilars company Formycon has announced that its 2025/2029 corporate bond was significantly oversubscribed due to ...

US biotech major Biogen today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of ...

Despite calls for the meeting to be delayed, Wednesday’s meeting of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) went ahead.

In a significant showcase for investors, BeOne Medicines announced major advancements to its industry-leading oncology ...

Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

Indian drugmaker Biocon has announced that Health Canada has granted a Notice of Compliance for Yesafili (aflibercept), a ...

Japanese drugmaker Chugai Pharmaceutical today revealed that it has filed a regulatory application with the Ministry of ...